We recommend that CTC should be routinely assessed and measured at diagnosis as part of risk evaluation,” study researchers wrote.

(HealthDay News) — The U.S. Food and Drug Administration (FDA) announced that it will fast-track review of nine experimental drugs. The move is part of a Trump administration program aimed at ...

Citizen lobbyists with different political views went to Washington, D.C., to lobby Congress to support aid for people with cancer.

Our prediction model provides a useful framework for conveying tailored risk information simply and identifying women who may receive enhanced benefit from specific intervention strategies because ...

A new analysis reveals how deeply the U.S. drug supply chain depends on China, and experts warn that a trade war could leave American patients at risk.

This study found that smoking increased the risk of mortality among cancer survivors, even after adjusting for cancer type and stage,” researchers reported.

Incidence and mortality from renal cancer may double by 2050, according to a study published in European Urology.

Adjuvant ensartinib improves disease-free survival compared to placebo following complete resection of ALK-positive non-small cell lung cancer.

In MIBC patients, ctDNA-guided, adjuvant atezolizumab treatment is associated with significant survival improvements over placebo.

Long preoperative chemo elicited more pathologic complete responses than short preoperative chemo in PDAC, but no difference in EFS was seen.

First-line treatment with disitamab vedotin and toripalimab improved outcomes over chemotherapy in patients with HER2-expressing, locally advanced or metastatic urothelial carcinoma.

Therapeutic plasma exchange may allow patients with advanced melanoma to overcome immune checkpoint inhibitor resistance, data suggest.